9253 Results
1

Atlanta Journal Constitution: Here is why your face mask could be making you itchy

November 16, 2020

Yashu Dhamija, MD, presented a case study of a patient treated for contact dermatitis after a facial mask with elastics required him to seek hospital treatment. Dhamija, a first-year fellow at the University of Cincinnati College of Medicine, discussed his findings during this year’s virtual American College of Allergy, Asthma and Immunology Scientific meeting. Medica Magazine reported the finding and so did other media.

2

Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence?

April 14, 2022

A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 armamentarium. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

3

Local 12: COVID-19 antiviral pill in the works

September 29, 2021

Several companies, including Pfizer are developing a pill to fight COVID-19 symptoms. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by WKRC-TV, Local12 for a story about the antiviral medications and explained how they work.

5

Medscape: Merck's new COVID pill: 'Game-changer' or just one more tool?

October 11, 2021

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources cited in an article in Medscape on pharmaceutical company Merck developing a new pill for COVID-19. Fichtenbaum said it wasn't a 'home run' but it was encouraging.

7

Giddy: Here we go again: The return of the common cold

November 10, 2021

With people wearing masks over the past 18 months or so to ward off COVID-19, the incidence of the common cold has been reduced during that time. However, as more people get vaccines and boosters, and mask mandates are eased in some instances, the common cold could be poised to make a comeback as we head into the fall and winter months. Giddy posted a primer on what causes the common cold and how to combat it and one of the expert sources they cited was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

8

Health: Antidepressant for COVID-19 reduces hospitalization risk, a new study finds

October 29, 2021

The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study showed the drug showed a reduced risk of hospitalization and death among COVID patients. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a Health.com story on the study results.

9

Local 12: Misunderstood guidelines about COVID-19 overwhelming doctors

January 19, 2022

The recent surge in COVID-19 is driving the number of cases to record highs in the course of the pandemic. The impact is being felt at area hospitals who continue to battle the pandemic. In a story published by WKRC-TV, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, said that the surge is putting a lot of stress on healthcare providers.

10

WVXU: A mounting number of COVID patients continue to report lingering aftereffects

January 6, 2022

More and more people who contract COVID-19 are experiencing symptoms for an extended period of time. In a story on this produced by WVXU, Richard Becker, MD, professor and director, UC Heart, Lung and Vascular Institute and UC Division of Cardiovascular Health and Disease, who runs a long COVID clinic at UC Medical Center, said some patients are seeing symptoms last as long as a year and a half.